Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC

NCT06552234

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • CH Aix-en-Provence Aix-en-Provence, Bouches Du Rhône, France
  • AP-HM Marseille, Bouches Du Rhône, France
  • HIA Sainte Anne Toulon, Var, France
  • CHU Angers Angers, France
View all 20 locations
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

NCT07288177

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Compassionate Cancer Care Center Fountain Valley, California, United States
  • Providence Medical Foundation (St. Joseph Heritage Healthcare) Santa Rosa, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 41 locations
View Trial Details
Recruiting

A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy

NCT06931717

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Wien AKH Vienna, Austria
  • North Estonia Medical Centre Foundation Talinn, Estonia
  • CHU d'Angers Angers, France
  • Centre hospitalier d'Avignon Avignon, France
View all 35 locations
View Trial Details
Recruiting

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

NCT06780085

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Kentucky Chandler Medical Center ( Site 0019) Lexington, Kentucky, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
  • AHN Cancer Institute - Allegheny General ( Site 9501) Pittsburgh, Pennsylvania, United States
  • Centro de Estudios Clínicos SAGA ( Site 0161) Santiago, Region M. de Santiago, Chile
View all 34 locations
View Trial Details
Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

NCT05498428

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of California at San Diego La Jolla, California, United States
  • University of California Irvine Orange, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 110 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

NCT07230691

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University Hospital Graz Graz, Austria
  • Klinikum Klagenfurt am Worthersee Klagenfurt, Austria
  • UZ Brussel Brussels, Belgium
  • UZ Antwerpen Edegem, Belgium
View all 75 locations
View Trial Details
Recruiting

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +24 more
Locations
  • Dana-Farber/Massachusetts General Hospital, Inc Boston, Massachusetts, United States
  • New Experimental Therapeutics of San Antonio LLC San Antonio, Texas, United States
  • START - South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
View Trial Details

Related conditions